Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $119.39 ($8.3M) on 2015-07-07, disclosed to the SEC on 2015-07-17.
Scheduled sale ($8.3M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $119.39 | 3,739 | $446K | 5.4% |
| 2 | $117.72 | 34,494 | $4.1M | 49.1% |
| 3 | $118.72 | 31,767 | $3.8M | 45.6% |
| Total | $118.26 avg | 70,000 | $8.3M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |